Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONFIRMS: Febuxostat vs Allopurinol in Gout
NCT00430248Phase 3Completed
- Sponsor
- Takeda
- Start
- Feb 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of febuxostat in gout and hyperuricemia (3 arms), sponsored by Takeda. Primary endpoint: Percentage of Subjects Whose Serum Urate Level is <6.0 mg/dL at 6 months. Started Feb 2007; status: completed.
02
Drugs
febuxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT00430248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430248.